drugset

drugset / Trial / NCT07474467

Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

NCT07474467 ↗

Phase 1/2 Not yet recruiting 31 enrolled CellinCells

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical trial was to evaluate the safety and efficacy of a single administration of TRTP-101 in adults with atrophic scars.

Timeline

Start: 2026-08-01
Primary completion: 2029-02-01
Completion: 2029-08-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TRTP-101	Cell therapy	—	Intramuscular

Indications